
Feldan Therapeutics
Creating better futures for patients, Feldan drives deep science and therapeutic innovation by enabling the intracellular delivery of ASO.
$16.5M Series B+ ·
Source: startupintros.com
Latest round on record: Series B+, September 2024, amount undisclosed.
Total raised: $29M across 2 sourced rounds
All 3 rounds ↓Signals
Feldan Therapeutics | 2981 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | startupintros.com | |
| Series B+ | $16.5M | — | startupintros.com | |
| Series A | $12.5M | — | startupintros.com |
Timeline
- Website created
Companies like Feldan Therapeutics
VVitarka TherapeuticsAAvro Life Science
CCollate$95M Series A · Jun 2026BBoca Biolistics$25M · Feb 2023
AAmpersand Biomedicines$65M Series B+ · Mar 2025
GGlycoEra$130M Series B+ · May 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/feldan-therapeutics (get a free API key).